Schwaederlé, M. C., Patel, S. P., Husain, H., Ikeda, M., Lanman, R. B., Banks, K. C., . . . Kurzrock, R. (2017). Utility of genomic assessment of blood-derived circulating tumor DNA (ctDNA) in patients with advanced lung adenocarcinoma. Clin Cancer Res.
Citación estilo ChicagoSchwaederlé, Maria C., Sandip P. Patel, Hatim Husain, Megumi Ikeda, Richard B. Lanman, Kimberly C. Banks, AmirAli Talasaz, Lyudmila Bazhenova, y Razelle Kurzrock. "Utility of Genomic Assessment of Blood-derived Circulating Tumor DNA (ctDNA) in Patients With Advanced Lung Adenocarcinoma." Clin Cancer Res 2017.
Cita MLASchwaederlé, Maria C., et al. "Utility of Genomic Assessment of Blood-derived Circulating Tumor DNA (ctDNA) in Patients With Advanced Lung Adenocarcinoma." Clin Cancer Res 2017.